Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Polymers
|
May 13, 2023
Implication of Freeze-Thaw Erosion and Mechanism Analysis of High-Performance Aromatic Liquid Crystal Fibers
Hai Wan, Yanping Wang, Wenbin Jin, et al.
Scientific Reports
|
December 29, 2024
A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study
Zhi Dong, Wenbin Jin, Jiao Wang, et al.
Physical Chemistry Chemical Physics : PCCP
|
April 8, 2017
Enhanced self-assembly for the solubilization of cholesterol in molecular solvent/ionic liquid mixtures
Wenbin Jin, Yuqi Ke, Xianxian Liu, et al.
Journal of Medicinal Chemistry
|
January 10, 2025
PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC)
Wenbin Jin, Li Yan, Linlin Li, et al.
RSC Medicinal Chemistry
|
September 9, 2024
<i>In vitro</i> identification of oridonin hybrids as potential anti-TNBC agents inducing cell cycle arrest and apoptosis by regulation of p21, γH2AX and cleaved PARP
Jinhua Ning, Nini Zhan, Zhanpan Wu, et al.
Journal of Medicinal Chemistry
|
September 5, 2023
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Zhihao Zha, Karl Ploessl, Seok Rye Choi, et al.
Journal of Medicinal Chemistry
|
March 7, 2024
Theranostic Agent Targeting Bone Metastasis: A Novel [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-DOTA-HBED-bisphosphonate
Wenbin Jin, Ruiyue Zhao, Ran Wang, et al.
International Journal of Biological Macromolecules
|
February 19, 2025
Two novel β-galactosidases from Aeromonas caviae with potential industrial applications in milk and catalytic mechanism analysis using molecular docking
Yongmei Lyu, Fengxiang Chen, Wanjie Mao, et al.
Molecular Pharmaceutics
|
April 29, 2026
Development and Preclinical Evaluation of Dual-Target <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled FAP-Bisphosphonate Radioligands with Enhanced Osteoma Retention
Ruiyue Zhao, Yuling Deng, Wenbin Jin, et al.
Molecular Pharmaceutics
|
December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>
Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Polymers
|
May 13, 2023
Implication of Freeze-Thaw Erosion and Mechanism Analysis of High-Performance Aromatic Liquid Crystal Fibers
Hai Wan, Yanping Wang, Wenbin Jin, et al.
Scientific Reports
|
December 29, 2024
A drug-drug co-amorphous system for highly improved solubility of breviscapine: an experimental and computational study
Zhi Dong, Wenbin Jin, Jiao Wang, et al.
Physical Chemistry Chemical Physics : PCCP
|
April 8, 2017
Enhanced self-assembly for the solubilization of cholesterol in molecular solvent/ionic liquid mixtures
Wenbin Jin, Yuqi Ke, Xianxian Liu, et al.
Journal of Medicinal Chemistry
|
January 10, 2025
PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC)
Wenbin Jin, Li Yan, Linlin Li, et al.
RSC Medicinal Chemistry
|
September 9, 2024
<i>In vitro</i> identification of oridonin hybrids as potential anti-TNBC agents inducing cell cycle arrest and apoptosis by regulation of p21, γH2AX and cleaved PARP
Jinhua Ning, Nini Zhan, Zhanpan Wu, et al.
Journal of Medicinal Chemistry
|
September 5, 2023
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
Zhihao Zha, Karl Ploessl, Seok Rye Choi, et al.
Journal of Medicinal Chemistry
|
March 7, 2024
Theranostic Agent Targeting Bone Metastasis: A Novel [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-DOTA-HBED-bisphosphonate
Wenbin Jin, Ruiyue Zhao, Ran Wang, et al.
International Journal of Biological Macromolecules
|
February 19, 2025
Two novel β-galactosidases from Aeromonas caviae with potential industrial applications in milk and catalytic mechanism analysis using molecular docking
Yongmei Lyu, Fengxiang Chen, Wanjie Mao, et al.
Molecular Pharmaceutics
|
April 29, 2026
Development and Preclinical Evaluation of Dual-Target <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled FAP-Bisphosphonate Radioligands with Enhanced Osteoma Retention
Ruiyue Zhao, Yuling Deng, Wenbin Jin, et al.
Molecular Pharmaceutics
|
December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>
Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Page
of 5